Reports for IRBESARTAN
Ingredient
IRBESARTAN
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2022-08-11 | 2022-08-11 | 166530 |
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2018-12-20 | 2019-02-27 | 70230 |
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2019-10-09 | 2020-01-24 | 95800 |
| AVALIDE | 150MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-20 | 132678 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-05-08 | 2019-05-10 | 83440 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-07-16 | 2020-01-24 | 89482 |
| AVALIDE | 12.5MG 300MG | TABLET | Avoided shortage | 2022-04-14 | 2022-08-11 | 158890 |
| AVAPRO | 150MG | TABLET | Resolved | 2020-07-10 | 2020-07-15 | 119930 |
| AVAPRO | 75MG | TABLET | Resolved | 2018-11-29 | 2019-02-27 | 68058 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 |